Clinical Trial Detail

NCT ID NCT02270788
Title Crenolanib in Combination With Sorafenib in Patients With Refractory or Relapsed Hematologic Malignancies
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors St. Jude Children's Research Hospital
Indications

acute myeloid leukemia

acute leukemia

Therapies

Cytarabine + Leucovorin + Methotrexate

Crenolanib + Sorafenib

Age Groups: adult child

Additional content available in CKB BOOST